Patents - Global Data - Dimensions
Application
The dosage of controlled release PTH compound
Applicants
- Arsendis Drug Bone Disease Co Ltd
Abstract
The present invention relates to include at least one controlled release PTH compound or its pharmaceutically acceptable salt, the pharmaceutical composition of hydrate or solvate, it is used to treat, control, delay or prevention can be treated with PTH, control, the illness of delay or prevention, include at least one controlled release PTH compound or its pharmaceutically acceptable salt, the pharmaceutical composition of hydrate or solvate, for treating, control, delay or prevention can be treated with PTH, control, the illness of delay or prevention, wherein the pharmaceutical composition is applied with being no more than every 24 hours 1 time frequency, wherein the dosage of controlled release PTH compound is equivalent to application in every 24 hours, the PTH 1-84 molar equivalent dosage for maintaining human serum calcium required in normal level within 24 hour time limit is no more than 70%.
Patent Family Records (38)
Controlled-release PTH compound
Ascendis Pharma Bone Diseases AS SPROGÿE KENNETT, SPROGØE KENNETT, CLEEMANN FELIX, (...more)
2024, US-11918628-B2
Controlled-release PTH compound
Ascendis Pharma Bone Diseases AS SPROGÿE KENNETT, SPROGØE KENNETT, CLEEMANN FELIX, (...more)
2024, US-11890326-B2
DOSAGE REGIMEN FOR A CONTROLLED-RELEASE PTH COMPOUND
ASCENDIS PHARMA BONE DISEASES A HOLTEN ANDERSEN LARS, HOLTEN-ANDERSEN LARS, SPROGE KENNETT, (...more)
2024, KR-20240013849-A
Dosage Regimen for Controlled Release PTH Compounds
아센디스 파마 본 디지즈 에이/에스 КАРПФ, Дэвид Брайан, СПРОГЕЕ, Кеннетт, ХОЛЬТЕН-АНДЕРСЕН, Ларс, (...more)
2024, KR-102627405-B1
DOSAGE REGIMEN FOR CONTROLLED-RELEASE PTH COMPOUND
Ascendis Pharma Bone Diseases AS LARS HOLTEN-ANDERSEN, KENNETT SPROGOE, DAVID BRIAN KARPF
2024, JP-2024041859-A
DOSAGE REGIMEN FOR A CONTROLLED-RELEASE PTH COMPOUND
ASCENDIS PHARMA BONE DISEASES AS HOLTEN ANDERSEN LARS, HOLTEN-ANDERSEN LARS, SPROGOE KENNETT, (...more)
2024, HU-E063235-T2
Dosing regimen for a controlled release pth compound
Ascendis Pharma Bone Diseases AS HOLTEN ANDERSEN LARS, HOLTEN-ANDERSEN LARS, SPROGÿE KENNETT, (...more)
2024, ES-2959995-T3
DOSAGE REGIMEN FOR A CONTROLLED-RELEASE PTH COMPOUND
Ascendis Pharma Bone Diseases AS HOLTEN ANDERSEN LARS, HOLTEN-ANDERSEN LARS, SPROGÿE KENNETT, (...more)
2024, EP-4275677-A3
Dosage regimen for controlled release of PTH compounds
Ascendis Pharma Bone Diseases AS HOLTEN ANDERSEN LARS, HOLTEN-ANDERSEN LARS, SPROGOE KENNETT, (...more)
2024, CN-117838873-A
Dosage regimen for controlled release of PTH compounds
Ascendis Pharma Bone Diseases AS L. Holden-Anderson, SPROGOEE KENNETT, D.B. Kapf
2024, CN-109789189-B
Controlled-Release PTH Compound
Ascendis Pharma Bone Diseases AS SPROGÿE KENNETT, SPROGØE KENNETT, CLEEMANN FELIX, (...more)
2023, US-20230381284-A1
Dosage Regimen for a Controlled-Release PTH Compound
Ascendis Pharma Bone Diseases AS SPROGÿE KENNETT, SPROGØE KENNETT, CLEEMANN FELIX, (...more)
2023, US-20230321198-A1
Dosage Regimen for a Controlled-Release PTH Compound
Ascendis Pharma Bone Diseases AS SPROGÿE KENNETT, SPROGØE KENNETT, CLEEMANN FELIX, (...more)
2023, US-20230248836-A1
Dosage regimen for a controlled-release PTH compound
Ascendis Pharma Bone Diseases AS HOLTEN ANDERSEN LARS, HOLTEN-ANDERSEN LARS, SPROGÿE KENNETT, (...more)
2023, US-11590207-B2
DOSAGE REGIMEN FOR A CONTROLLED-RELEASE PTH COMPOUND
ASCENDIS PHARMA BONE DISEASES AS HOLTEN ANDERSEN LARS, HOLTEN-ANDERSEN LARS, SPROGOE KENNETT, (...more)
2023, SI-3518960-T1
DOSAGE REGIMEN FOR A CONTROLLED-RELEASE PTH COMPOUND
ASCENDIS PHARMA BONE DISEASES AS HOLTEN ANDERSEN LARS, HOLTEN-ANDERSEN LARS, SPROGÿE KENNETT, (...more)
2023, RS-64440-B1
DOSAGE REGIMEN FOR A CONTROLLED-RELEASE PTH COMPOUND
ASCENDIS PHARMA BONE DISEASES AS HOLTEN ANDERSEN LARS, HOLTEN-ANDERSEN LARS, SPROGÿE KENNETT, (...more)
2023, PL-3518960-T3
DOSAGE REGIMEN FOR A CONTROLLED-RELEASE PTH COMPOUND
ASCENDIS PHARMA BONE DISEASES AS HOLTEN ANDERSEN LARS, HOLTEN-ANDERSEN LARS, SPROGÿE KENNETT, (...more)
2023, LT-3518960-T
Dosing Regimens for Controlled-Release PTH Compounds
Ascendis Pharma Bone Diseases AS LARS HOLTEN-ANDERSEN, KENNETT SPROGOE, DAVID BRIAN KARPF
2023, JP-2023017796-A
DOSAGE REGIMEN FOR A CONTROLLED-RELEASE PTH COMPOUND
ASCENDIS PHARMA BONE DISEASES AS
2023, IL-304086-A
DOSAGE REGIMEN FOR A CONTROLLED-RELEASE PTH COMPOUND
ASCENDIS PHARMA BONE DISEASES AS
2023, IL-265591-B2
Dosage regimen for a controlled-release pth compound
ASCENDIS PHARMA BONE DISEASES AS
2023, IL-265591-B1
DOSAGE REGIMEN FOR A CONTROLLED-RELEASE PTH COMPOUND
ASCENDIS PHARMA BONE DISEASES AS HOLTEN ANDERSEN LARS, HOLTEN-ANDERSEN LARS, SPROGÿE KENNETT, (...more)
2023, HR-P20231079-T1
DOSAGE REGIMEN FOR A CONTROLLED-RELEASE PTH COMPOUND
Ascendis Pharma Bone Diseases AS HOLTEN ANDERSEN LARS, HOLTEN-ANDERSEN LARS, SPROGÿE KENNETT, (...more)
2023, EP-4275677-A2
DOSAGE REGIMEN FOR A CONTROLLED-RELEASE PTH COMPOUND
Ascendis Pharma Bone Diseases AS HOLTEN ANDERSEN LARS, HOLTEN-ANDERSEN LARS, SPROGÿE KENNETT, (...more)
2023, EP-3518960-B1
Dosage schedule for a controlled release PTH compound
ASCENDIS PHARMA BONE DISEASES AS HOLTEN ANDERSEN LARS, HOLTEN-ANDERSEN LARS, KARPF DAVID BRIAN, (...more)
2023, DK-3518960-T3
Dosage Regimen for a Controlled-Release PTH Compound
Ascendis Pharma Bone Diseases AS HOLTEN ANDERSEN LARS, HOLTEN-ANDERSEN LARS, SPROGÿE KENNETT, (...more)
2020, US-20200023041-A1
CONTROLLED RELEASE PTH CONNECTION DOSING MODE
Асцендис Фарма Боун Дизизис А/С КАРПФ, Дэвид Брайан, СПРОГЕЕ, Кеннетт, ХОЛЬТЕН-АНДЕРСЕН, Ларс, (...more)
2020, RU-2019112913-A
DOSAGE REGIMEN FOR A CONTROLLED-RELEASE PTH COMPOUND
ASCENDIS PHARMA BONE DISEASES AS HOLTEN ANDERSEN LARS, HOLTEN-ANDERSEN LARS, SPROGÿE KENNETT, (...more)
2019, ZA-201901811-B
DOSAGE REGIMEN FOR A CONTROLLED-RELEASE PTH COMPOUND
ASCENDIS PHARMA BONE DISEASES AS HOLTEN ANDERSEN LARS, HOLTEN-ANDERSEN LARS, SPROGÿE KENNETT, (...more)
2019, SG-11201901576Q-A
DOSAGE REGIMEN FOR A CONTROLLED-RELEASE PTH COMPOUND.
ASCENDIS PHARMA BONE DISEASES AS KENNETT SPROGØE, LARS HOLTEN-ANDERSEN, DAVID BRIAN KARPF
2019, MX-2019003181-A
Dosage regimen for controlled-release PTH compound
ASCENDIS PHARMA BONE DISEASES A HOLTEN ANDERSEN LARS, HOLTEN-ANDERSEN LARS, SPROGÿE KENNETT, (...more)
2019, KR-20190062496-A
DOSAGE REGIMEN FOR A CONTROLLED-RELEASE PTH COMPOUND
Ascendis Pharma Bone Diseases AS HOLTEN ANDERSEN LARS, HOLTEN-ANDERSEN LARS, SPROGÿE KENNETT, (...more)
2019, EP-3518960-A1
The dosage of controlled release PTH compound
Arsendis Drug Bone Disease Co Ltd HOLTEN ANDERSEN LARS, HOLTEN-ANDERSEN LARS, SPROGOE KENNETT, (...more)
2019, CN-109789189-A
dosing regimen for a controlled release pth compound
ASCENDIS PHARMA BONE DISEASES AS DAVID BRIAN KARPF, KENNETT SPROGØE, LARS HOLTEN-ANDERSEN
2019, BR-112019005533-A2
Dosage regimen for a controlled-release PTH compound
Ascendis Pharma Bone Diseases AS HOLTEN ANDERSEN LARS, HOLTEN-ANDERSEN LARS, SPROGÿE KENNETT, (...more)
2019, AU-2017336249-A1
DOSAGE REGIMEN FOR A CONTROLLED-RELEASE PTH COMPOUND
ASCENDIS PHARMA BONE DISEASES AS HOLTEN ANDERSEN LARS, HOLTEN-ANDERSEN LARS, SPROGÿE KENNETT, (...more)
2018, WO-2018060310-A1
DOSAGE REGIMEN FOR A CONTROLLED-RELEASE PTH COMPOUND
Ascendis Pharma Bone Diseases AS HOLTEN ANDERSEN LARS, HOLTEN-ANDERSEN LARS, SPROGOE KENNETT, (...more)
2018, CA-3037442-A1